Compare KSPI & ALGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KSPI | ALGN |
|---|---|---|
| Founded | 2008 | 1997 |
| Country | Kazakhstan | United States |
| Employees | N/A | N/A |
| Industry | | Industrial Specialties |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.6B | 11.9B |
| IPO Year | 2024 | N/A |
| Metric | KSPI | ALGN |
|---|---|---|
| Price | $79.31 | $161.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 14 |
| Target Price | $113.00 | ★ $188.92 |
| AVG Volume (30 Days) | 542.1K | ★ 1.7M |
| Earning Date | 11-10-2025 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 13.36 | N/A |
| EPS | ★ 10.48 | 5.16 |
| Revenue | ★ $6,665,289,776.00 | $3,982,622,000.00 |
| Revenue This Year | $39.99 | $2.58 |
| Revenue Next Year | $19.87 | $3.41 |
| P/E Ratio | ★ $7.52 | $31.11 |
| Revenue Growth | ★ 54.22 | 0.56 |
| 52 Week Low | $70.61 | $122.00 |
| 52 Week High | $111.45 | $237.23 |
| Indicator | KSPI | ALGN |
|---|---|---|
| Relative Strength Index (RSI) | 62.39 | 67.04 |
| Support Level | $74.98 | $159.40 |
| Resistance Level | $77.77 | $165.26 |
| Average True Range (ATR) | 2.12 | 4.39 |
| MACD | 0.42 | 0.13 |
| Stochastic Oscillator | 80.11 | 74.02 |
Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform that connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.